Auditorium Via Rieti
Via Rieti 13
Rome
Italy
This workshop is now accessible also via online attendance.
The event has limited availability and is free of charge for medical trainees and
specialists, lab technicians, researchers and nurses.
The registration fee for pharma company employees is equal to 300€.
Register here and choose to attend in presence or remotely.
Overview
The International Workshop on Antibody-Mediated Neurological Diseases is set as a key event to update the medical-scientific community on the latest developments in the field of antibody-mediated neurological disorders. With a specific focus on conditions such as myasthenia gravis, autoimmune encephalitis, and neuromyelitis optica spectrum disorders, the workshop aims to provide a holistic understanding that ranges from pathogenesis to the latest innovations in diagnostic and therapeutic fields. Particular emphasis will be given to diagnostic challenges, through the analysis of complex clinical cases and the illustration of how new technologies are revolutionizing the study of autoimmune neurological diseases. The workshop intends to stimulate constructive and interdisciplinary dialogue, promoting integration between clinical practice and advanced biotechnologies.
The event promises to be a unique opportunity for multidisciplinary learning and for creating professional networks, essential to effectively respond to the challenges posed by antibody-mediated neurological diseases.
Endorsements
This educational activity is endorsed by:
Learning Objectives
- Provide a comprehensive update on the latest research and discoveries in antibody-mediated neurological diseases.
- Discuss in-depth advances in biomarkers, diagnostic techniques, and therapeutic strategies for these conditions.
- Analyze diagnostic challenges, including differential diagnoses, through the exploration of detailed clinical cases.
- Illustrate the use of new technologies in the study and management of autoimmune neurological diseases.
- Encourage collaboration and the exchange of ideas among professionals from various medical, scientific, and technological disciplines.
Target Audience
The workshop is designed for:
- Medical trainees and specialists in Neurology, Psychiatry, and Child Neuropsychiatry.
- Medical specialists in Ophthalmology, Infectious Diseases, Microbiology, Radiology, Pathological Anatomy, Anesthesia and Resuscitation, Hematology, and Oncology.
- PhD candidates and researchers in Neuroscience, Biologists, Biotechnologists, and Psychologists.
- Laboratory and neurophysiopathology technicians.
- Nurses specialized in neurosciences and neurological diseases.
Scientific Organizer
Raffaele Iorio
Department of Neuroscience Università Cattolica del Sacro Cuore Rome, Italy
CME Accreditation
The International Workshop on Antibody-Mediated Neurological Diseases, Rome, Italy 19/10/2024 - 19/10/2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 6.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications .
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
The programme has been also accredited by the Italian Ministry of Health by the CME provider SMM srl (Id. 5129) as follows:
Event number: 425011 - CME Credits: 6
Venue
Auditorium Via Rieti
Via Rieti 13, Rome, Italy
SCIENTIFIC Programme
08:30 - 08.40 Welcome Address
P. Calabresi, Italy - A. Evoli, Italy - R. Iorio, Italy
Chairmen: P. Calabresi, Italy - R. Iorio, Italy
08.40-09.00 Keynote Speech: The role of B cells in Neurological Autoimmunity
K. O’Connor, USA
Session 1: Myasthenia Gravis
Chairmen: C. Antozzi, Italy - M.P. Giannoccaro, Italy
09.00-09.20 Diagnostic and Therapeutic Challenges in Myasthenia Gravis
A.Evoli, Italy
09.20-09.40 The role of complement activation in myasthenia gravis: looking for biomarkers
S. Hoffmann, Germany
09.40-10.00 Immunopathogenesis of MuSK-MG
MG. Huijbers, The Netherlands
10.00-10.20 Cellular immunotherapies for Myasthenia Gravis
A. Payne, USA
10.20-10.35 Q&A
10.35-10.55 Coffee Break and Poster Exhibition
Session 2: Neuromyelitis Optica Spectrum Disorders (NMOSD)
Chairmen: S. Mariotto, Italy - E. Sechi, Italy
10.55-11.15 Immunopathogenesis of MOGAD and AQP4 Autoimmune Disorders: Insights for Improving Treatment Outcomes
R. Marignier, France
11.15-11.35 Diagnostic and therapeutic challenges in MOGAD and AQP4 autoimmunity
A. Cobo Calvo, Spain
11.35-11.55 Traditional and advanced Neuroimaging in MOGAD and AQP4 Autoimmunity
R. Cortese, Italy
11.55-12.10 Q&A
12.10-13.10 Lunch and Poster Exhibition
Session 3: Autoimmune Encephalitis
Chairmen: M. Gastaldi, Italy - L. Zuliani, Italy
13.10-13.30 The Complex Interplay between Genetics and Environment in the pathogenesis of Autoimmune encephalitis
S. Muniz Castrillo, Spain
13.30-13.50 Pathogenic mechanisms of Autoimmune Encephalitis
M. Spatola, Spain
13.50-14.10 Human recombinant monoclonal antibodies and CAAR-T cells in autoimmune encephalitis
H. Pruss, Germany
14.10-14.30 Unity is Strength: how Collaboration Networks can advance the field of Autoimmune Encephalitis
F. Leypoldt, Germany
14.30-14.55 Q&A
14.55-15.15 Coffee Break and Poster Exhibition
Session 4: Harnessing Novel Technologies to Unravel Neurological Autoimmunity
Chairmen: R. Iorio, Italy - A. Vogrig, Italy
15.15-15.35 Thymic organoids: opportunities and challenges to study central tolerance
L. Sangho, The Netherlands
15.35-15.55 The impact of structural biology on understanding the pathogenic mechanisms of autoimmune neurological diseases
C. Noviello, USA
15.55-16.15 Single-cell multiomics to investigate antibody-mediated neurological diseases
B. Schreiner, Switzerland
16.15-16.30 Q&A
16.30 Closing Remarks
16.40 End of the workshop